{"log_id": 5239181188909389829, "direction": 0, "words_result_num": 44, "words_result": [{"probability": {"variance": 0.002364, "average": 0.967781, "min": 0.864512}, "location": {"width": 110, "top": 192, "height": 25, "left": 226}, "words": "【用法用量】"}, {"probability": {"variance": 0.003151, "average": 0.98153, "min": 0.681226}, "location": {"width": 744, "top": 223, "height": 26, "left": 262}, "words": "抗肿瘤化疗:本可供肌肉、静脉途径给药,每瓶Smg的冻干粉针用大约2ml注射用"}, {"probability": {"variance": 0.013527, "average": 0.946979, "min": 0.476179}, "location": {"width": 787, "top": 255, "height": 24, "left": 220}, "words": "水重溶为2.5mg/ml的浓度,每瓶0.1g的冻干粉针用大约4ml注射用水重溶为25mg/ml的浓"}, {"probability": {"variance": 0.02709, "average": 0.903019, "min": 0.393029}, "location": {"width": 785, "top": 285, "height": 25, "left": 221}, "words": "度,每瓶1g的冻千粉用大约20ml注射用水溶为50mg/ml的浓度。如有需要可无菌"}, {"probability": {"variance": 0.024938, "average": 0.903174, "min": 0.398045}, "location": {"width": 784, "top": 314, "height": 26, "left": 221}, "words": "和不含防腐剂的溶媒迎一步使用,如注射用氯化钠溶液戏5%葡萄糖溶液。当大剂量静"}, {"probability": {"variance": 0.000329, "average": 0.986898, "min": 0.932789}, "location": {"width": 356, "top": 345, "height": 25, "left": 221}, "words": "脉给药时,适宜用5%葡萄糖注射液"}, {"probability": {"variance": 0.006472, "average": 0.963725, "min": 0.585147}, "location": {"width": 720, "top": 375, "height": 26, "left": 267}, "words": "绒毛膜癌及类似滋养层疾病,常规量是15~30mg/日,肌注5天。通常一至数周后"}, {"probability": {"variance": 0.001769, "average": 0.983229, "min": 0.829642}, "location": {"width": 618, "top": 406, "height": 25, "left": 222}, "words": "在所有毒性反应全部消失后,再开始下一个疗程。通常需要3~5个疗程"}, {"probability": {"variance": 0.000883, "average": 0.990187, "min": 0.812441}, "location": {"width": 744, "top": 435, "height": 27, "left": 263}, "words": "治疗的有效性可采用24小时尿HCG(人绒毛膜促性腺激素)定量分析进行评估。在第"}, {"probability": {"variance": 0.011531, "average": 0.949356, "min": 0.571644}, "location": {"width": 779, "top": 464, "height": 27, "left": 222}, "words": "三次或第四次疗程后,HCG水平应回到正常或低于S0IU/24h,通常可测定的病变在约46"}, {"probability": {"variance": 0.010456, "average": 0.976559, "min": 0.354282}, "location": {"width": 772, "top": 496, "height": 26, "left": 222}, "words": "周后可完全消除。在HCG水平恢复正常后,建议继续给予或2个疗程甲氨蝶呤的治疗"}, {"probability": {"variance": 0.002097, "average": 0.989351, "min": 0.716227}, "location": {"width": 734, "top": 527, "height": 26, "left": 264}, "words": "每个治疗开始前,必须进行仔细地临床评估,甲氨蝶呤与可其它抗肿瘤药物联合使用"}, {"probability": {"variance": 0.005144, "average": 0.980169, "min": 0.607758}, "location": {"width": 741, "top": 557, "height": 27, "left": 265}, "words": "乳腺癌:对丁淋巴结阳性的早期乳腺癌病人,作为乳房根治切除术后的辅助疗法,甲"}, {"probability": {"variance": 0.004749, "average": 0.965021, "min": 0.686483}, "location": {"width": 785, "top": 588, "height": 27, "left": 221}, "words": "氨蝶呤与环磷酰胺、氟尿嘧啶联合应用,交替进行长期化疗可行到较好的疗效。甲氨蝶呤的"}, {"probability": {"variance": 0.001537, "average": 0.981008, "min": 0.830526}, "location": {"width": 401, "top": 618, "height": 24, "left": 222}, "words": "剂量为40mg/m2,于第一天和第八天静脉给药"}, {"probability": {"variance": 0.00051, "average": 0.991237, "min": 0.881934}, "location": {"width": 741, "top": 645, "height": 28, "left": 266}, "words": "白血病:甲氨蝶呤与皮质类固醇及其它抗白血病药物的联合使用似可快速有效地缓解"}, {"probability": {"variance": 0.016686, "average": 0.949243, "min": 0.363075}, "location": {"width": 783, "top": 677, "height": 27, "left": 223}, "words": "白血病,甲氨蝶呤的剂量为每天口服3.3mgn2,合用强的松60mg/m2/日。如有缓解,可改"}, {"probability": {"variance": 0.001688, "average": 0.97892, "min": 0.754451}, "location": {"width": 769, "top": 708, "height": 27, "left": 222}, "words": "用甲氨蝶呤维持剂量,每次30mg/m3口服或肌注,每周二次:或每14天静脉给药2.5mg/kg"}, {"probability": {"variance": 0.01402, "average": 0.950635, "min": 0.397136}, "location": {"width": 758, "top": 738, "height": 25, "left": 223}, "words": "当复发时,可用诱导方重复药。急性检细胞性白血病对化学疗法不敏感。其缓解时间短"}, {"probability": {"variance": 3.2e-05, "average": 0.99704, "min": 0.979043}, "location": {"width": 243, "top": 769, "height": 23, "left": 223}, "words": "易于复发和迅速产生耐药性"}, {"probability": {"variance": 0.004593, "average": 0.978029, "min": 0.572011}, "location": {"width": 739, "top": 798, "height": 27, "left": 268}, "words": "叉样霉菌病:甲氨蝶呤50mg每周一次或25mg每周二次肌注,可以做为口服疗法的替"}, {"probability": {"variance": 0, "average": 0.999735, "min": 0.999347}, "location": {"width": 63, "top": 831, "height": 23, "left": 224}, "words": "代方法"}, {"probability": {"variance": 0.000999, "average": 0.984664, "min": 0.842353}, "location": {"width": 723, "top": 859, "height": 28, "left": 265}, "words": "大剂量疗法:给药方案应根据病史、疾病的严重程度以及医师的临床经验加以调整"}, {"probability": {"variance": 0.012046, "average": 0.953817, "min": 0.483775}, "location": {"width": 769, "top": 891, "height": 25, "left": 224}, "words": "大剂量给药方案应在具备处理不良反应的充分设备的条件下,由专家执行【参见注意事项】"}, {"probability": {"variance": 0.002143, "average": 0.980027, "min": 0.798106}, "location": {"width": 744, "top": 952, "height": 28, "left": 263}, "words": "银屑病化疗:治疗银屑病的给药方案主要依据病情的性质和严重程度及医师自身的经验"}, {"probability": {"variance": 0.00019, "average": 0.98601, "min": 0.972223}, "location": {"width": 42, "top": 985, "height": 23, "left": 225}, "words": "而定"}, {"probability": {"variance": 0.011452, "average": 0.970079, "min": 0.480056}, "location": {"width": 742, "top": 1014, "height": 29, "left": 265}, "words": "应事先告知患者所有可能的危险,并在治疗过程中持续监测患者情况。对肾功能、肝功"}, {"probability": {"variance": 0.003211, "average": 0.981701, "min": 0.640809}, "location": {"width": 781, "top": 1046, "height": 28, "left": 226}, "words": "能和血液成分的评估应该有历史记录。在甲氨蝶呤开始治疗之前、治疗期间定期的以及间隔"}, {"probability": {"variance": 0.002227, "average": 0.980009, "min": 0.751726}, "location": {"width": 754, "top": 1076, "height": 28, "left": 245}, "words": "段时间后重新开始本品治疗之前都需要进行体格检查和实验室检查(例如全血细胞计数"}, {"probability": {"variance": 0.009013, "average": 0.955561, "min": 0.56729}, "location": {"width": 776, "top": 1108, "height": 27, "left": 225}, "words": "尿检验、血清肌酐测定、肝功能测定以及必要时行肝脏穿刺活检)在接受和结束甲氨蝶呤"}, {"probability": {"variance": 0.004056, "average": 0.975075, "min": 0.715992}, "location": {"width": 402, "top": 1139, "height": 28, "left": 226}, "words": "治疗后至少3个月内应该采取适当的措施避孕"}, {"probability": {"variance": 0.002626, "average": 0.974866, "min": 0.774133}, "location": {"width": 518, "top": 1171, "height": 25, "left": 264}, "words": "依据每周胃肠外歇性大剂用法制定常州注射剂量计划表"}, {"probability": {"variance": 0.031105, "average": 0.906644, "min": 0.411103}, "location": {"width": 743, "top": 1201, "height": 28, "left": 264}, "words": "计划表应该针对个体患者不断调整一下述引的针计划表适用于平均体重70kg的成"}, {"probability": {"variance": 0.004177, "average": 0.974788, "min": 0.683952}, "location": {"width": 780, "top": 1233, "height": 26, "left": 228}, "words": "年人。推荐在开始治疗前的一周使用初始尝试剂来检测任何特异体质。建议胃肠外给药的"}, {"probability": {"variance": 0.000635, "average": 0.985347, "min": 0.908651}, "location": {"width": 170, "top": 1266, "height": 25, "left": 227}, "words": "剂量范围是5-10mg"}, {"probability": {"variance": 8.9e-05, "average": 0.987991, "min": 0.973261}, "location": {"width": 125, "top": 1296, "height": 25, "left": 268}, "words": "推荐起始剂"}, {"probability": {"variance": 0.008481, "average": 0.971145, "min": 0.433937}, "location": {"width": 734, "top": 1326, "height": 26, "left": 273}, "words": "每周肌肉或静脉注射单药给药方案:每周10-25mg到出现适当的疗效。在这个剂"}, {"probability": {"variance": 0.015089, "average": 0.960302, "min": 0.458879}, "location": {"width": 339, "top": 1359, "height": 25, "left": 226}, "words": "计划表中,量一般不能超过50mg/周"}, {"probability": {"variance": 0.00211, "average": 0.982406, "min": 0.785482}, "location": {"width": 743, "top": 1388, "height": 28, "left": 265}, "words": "要逐渐调整剂量以达到最佳的临床疗效,但在每个疗程中都不能超过最大剂量。一旦出"}, {"probability": {"variance": 0.019053, "average": 0.949964, "min": 0.351596}, "location": {"width": 782, "top": 1421, "height": 27, "left": 226}, "words": "现最佳临床疗效,剂计划表应该减到可能的最低量和最长的休息间期。应该鼓励甲氨蝶"}, {"probability": {"variance": 0.031946, "average": 0.90954, "min": 0.47229}, "location": {"width": 301, "top": 1454, "height": 24, "left": 227}, "words": "呤的使用可以恢复常规的局部治疗"}, {"probability": {"variance": 0, "average": 0.999466, "min": 0.998856}, "location": {"width": 109, "top": 1516, "height": 24, "left": 235}, "words": "【不良反应】"}, {"probability": {"variance": 0.025079, "average": 0.922711, "min": 0.377545}, "location": {"width": 740, "top": 1547, "height": 28, "left": 271}, "words": "甲氨蝶呤的主要性反应发生在常和增殖迅速的组织,特别是骨髓和胃肠道。口腔粘"}, {"probability": {"variance": 0.014081, "average": 0.955867, "min": 0.382885}, "location": {"width": 771, "top": 1579, "height": 26, "left": 227}, "words": "膜溃疡通常是性反应的最早期症状,最常见的不良反应包括溃疡性腔炎、白细胞减少"}], "language": 3}